bismuth subsalicylate 262 MG Chewable Tablet [Kaopectate Reformulated Aug 2006]
RxNorm concept 2476644, branded drug (sbd). Prescribable name: Kaopectate 262 MG Chewable Tablet, Reformulated Aug 2006.
- RxCUI
- 2476644
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2476644 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Kaopectate Reformulated Aug 2006 262 MG Chewable Tablet
Related concepts
- bismuth subsalicylate 262 MG (SCDC, consists of)
- bismuth subsalicylate 262 MG [Kaopectate Reformulated Aug 2006] (SBDC, consists of)
- Chewable Tablet (DF, has dose form)
- Kaopectate Reformulated Aug 2006 (BN, has ingredient)
- bismuth subsalicylate 262 MG Chewable Tablet (SCD, tradename of)
Linked data
NDCs
- 53076020669
- 55505020669
- 55505020679
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2476644 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2476644 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2476644. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.